Literature DB >> 11796584

Host defense functions of proteolytically processed and parent (unprocessed) cathelicidins of rabbit granulocytes.

Kol A Zarember1, Seth S Katz, Brian F Tack, Laurence Doukhan, Jerrold Weiss, Peter Elsbach.   

Abstract

Members of the cathelicidin family are present in all mammals studied. Generally, these proteins contain a conserved N-terminal domain and a structurally and functionally divergent C-terminal region that expresses antibacterial or other activities when proteolytically released. Rabbit granulocytes produce CAP18, a cathelicidin that conforms to this structural and functional organization, and also 15-kDa protein isoforms (p15s) that share several key structural features with other cathelicidins but apparently do not undergo processing with release of an active peptide. To further define the importance of proteolysis in the antibacterial activities of these proteins, we have purified from granulocytes proCAP18, its C-terminal peptide (CAP18p), and two p15 isoforms to apparent homogeneity. Of these four polypeptides, only CAP18p was independently cytotoxic to encapsulated Escherichia coli (90% inhibitory concentration, approximately 600 nM) but it was approximately 50-fold less potent on a molar basis than the bactericidal/permeability-increasing protein (BPI). However, all four cathelicidin species, notably including proCAP18, exhibited antibacterial synergy with BPI, and the p15s also displayed synergy with CAP18p in the absence of BPI. Subnanomolar concentrations of proCAP18 blocked lipopolysaccharide-induced chemiluminescence of human leukocytes, showing a molar potency more than 100-fold greater than that of CAP18p ( approximately 20 nM) or BPI ( approximately 50 nM). Thus, while independent bactericidal activity of cathelicidins requires processing, other host-defense functions do not and are more potently expressed by the unprocessed protein than by the C-terminal peptide.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796584      PMCID: PMC127701          DOI: 10.1128/IAI.70.2.569-576.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma.

Authors:  O Sørensen; T Bratt; A H Johnsen; M T Madsen; N Borregaard
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

2.  Isolation of two isoforms of a novel 15-kDa protein from rabbit polymorphonuclear leukocytes that modulate the antibacterial actions of other leukocyte proteins.

Authors:  C E Ooi; J Weiss; O Levy; P Elsbach
Journal:  J Biol Chem       Date:  1990-09-15       Impact factor: 5.157

3.  The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils.

Authors:  O Sørensen; K Arnljots; J B Cowland; D F Bainton; N Borregaard
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

4.  The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.

Authors:  M N Marra; C G Wilde; M S Collins; J L Snable; M B Thornton; R W Scott
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

5.  Assay of antibacterial activities of the bactericidal/permeability-increasing protein in natural biological fluids.

Authors:  J Weiss
Journal:  Methods Mol Biol       Date:  1997

6.  Stimulus-induced maturation of probactenecins, precursors of neutrophil antimicrobial polypeptides.

Authors:  M Zanetti; L Litteri; G Griffiths; R Gennaro; D Romeo
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

7.  Comparative studies on the extracellular release and biological activity of guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and defensins.

Authors:  S Yomogida; I Nagaoka; T Yamashita
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1997-01       Impact factor: 2.231

8.  Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity.

Authors:  M Hirata; Y Shimomura; M Yoshida; J G Morgan; I Palings; D Wilson; M H Yen; S C Wright; J W Larrick
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

9.  The role of protegrins and other elastase-activated polypeptides in the bactericidal properties of porcine inflammatory fluids.

Authors:  J Shi; T Ganz
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

10.  Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules.

Authors:  M Zanetti; L Litteri; R Gennaro; H Horstmann; D Romeo
Journal:  J Cell Biol       Date:  1990-10       Impact factor: 10.539

View more
  10 in total

Review 1.  What is the real role of antimicrobial polypeptides that can mediate several other inflammatory responses?

Authors:  Peter Elsbach
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 2.  Endogenous production of antimicrobial peptides in innate immunity and human disease.

Authors:  Richard L Gallo; Victor Nizet
Journal:  Curr Allergy Asthma Rep       Date:  2003-09       Impact factor: 4.806

3.  Activation of cathepsin L by the cathelin-like domain of protegrin-3.

Authors:  Shunyi Zhu; Liang Wei; Kenshi Yamasaki; Richard L Gallo
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

4.  Structure-function analyses involving palindromic analogs of tritrypticin suggest autonomy of anti-endotoxin and antibacterial activities.

Authors:  Kanwal J Kaur; Pampi Sarkar; Sushma Nagpal; Tarique Khan; Dinakar M Salunke
Journal:  Protein Sci       Date:  2008-01-24       Impact factor: 6.725

5.  Cathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions.

Authors:  Josh C Woloszynek; Ying Hu; Christine T N Pham
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

6.  Heterologous Expression and Functional Characterization of CAP18 from Oryctolagus cuniculus.

Authors:  Mahla Nikpoor; Azadeh Lohrasbi-Nejad; Jafar Zolala
Journal:  Rep Biochem Mol Biol       Date:  2022-01

7.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

Authors:  Rembert Koczulla; Georges von Degenfeld; Christian Kupatt; Florian Krötz; Stefan Zahler; Torsten Gloe; Katja Issbrücker; Pia Unterberger; Mohamed Zaiou; Corinna Lebherz; Alexander Karl; Philip Raake; Achim Pfosser; Peter Boekstegers; Ulrich Welsch; Pieter S Hiemstra; Claus Vogelmeier; Richard L Gallo; Matthias Clauss; Robert Bals
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

8.  Structural and functional analysis of the pro-domain of human cathelicidin, LL-37.

Authors:  Marzena Pazgier; Bryan Ericksen; Minhua Ling; Eric Toth; Jishu Shi; Xiangdong Li; Amy Galliher-Beckley; Liqiong Lan; Guozhang Zou; Changyou Zhan; Weirong Yuan; Edwin Pozharski; Wuyuan Lu
Journal:  Biochemistry       Date:  2013-02-21       Impact factor: 3.162

9.  Avian antimicrobial host defense peptides: from biology to therapeutic applications.

Authors:  Guolong Zhang; Lakshmi T Sunkara
Journal:  Pharmaceuticals (Basel)       Date:  2014-02-27

10.  Identification of a novel cathelicidin antimicrobial peptide from ducks and determination of its functional activity and antibacterial mechanism.

Authors:  Wei Gao; Liwei Xing; Pei Qu; Tingting Tan; Na Yang; Dan Li; Huixian Chen; Xingjun Feng
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.